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Treatment of pectus excavatum: Bioabsorbable or 
metal strut? 
To the Editor: 
We appreciate the article by Matsui and colleagues 1 
reporting their use of a bioabsorbable poly-L-lactide 
strut for chest wall reconstruction i 23 patients with 
chronic sternal dehiscence and 33 patients with pectus 
excavatum. Use of this material is an alternative to 
temporary fixation by a metal strut, which requires 
surgical removal at a variable period after implantation. 
However, 6% of the patients with pectus excavatum 
treated with poly-L-lactide needed the strut to be 
removed because of overgrowth of granulation tissue 
around the poly-L-lactide, maybe because the bioab- 
sorbable strut was not thick enough to support the 
severe chest deformity. 
Since 1958 we have treated pectus excavatum by means 
of a personal technique (Actis Dato-Panero) involving 
internal strut fixation by a self-retaining seagull wing 
prosthesis. 2 The surgical technique consists of a longitudi- 
nal and a transverse temotomy in the higher portion of the 
convex zone and in the most depressed sternal portion. 
After this osteotomy a wedge resection of the ribs is 
performed to allow easier displacement of the sternal 
fragments (Fig. 1). 
A stainless steel strut (Sorin Biomedica, Saluggia, 
Vercelli, Italy) of appropriate size, molded into a seagull 
wing, is then positioned under the sternum, allocated 
over the ribs with its lateral wings. Sternal resections 
act like a hinge mechanism allowing a good correction. 
Few steel wires are used to stabilize the sternal frag- 
ments. 
The design of this self-retaining prosthesis allows good 
support, and the prosthesis can be removed after 8 to 12 
months through a small skin incision with local anesthesia 
in a day hospital (Fig. 2). 
A recent review of the records of 315 patients operated 
on with this technique (1958 to 1991) showed a tow 
incidence of complications immediately after the opera- 
tion and at long-term follow-u p (Table I). We did not 
observe any impairment of chest wall growth when the 
strut was extracted after 12 months) 
We have some reservations about using the bioabsorb- 
able strut as an alternative to the metal strut. 
1. The use of a bioabsorbable material will always 
induce undesirable reactions, often impossible to foresee, 
because different patients have different reactions. By 
contrast, a metal strut has good biologic tolerance and 
does not induce rejection. 
2. To obtain good consolidation after a large resection 
of the sternum and the ribs for chest deformity, a stabili- 
zation period of 6 to 8 months is often desirable because 
of the tendency for regression. The bioabsorbable strut 
cannot ensure more than 3 months of stabilization, but a 
Fig. 1. Surgical technique of implantation of seagull wing 
prosthesis. The body of the prosthesis ustains the ster- 
num and the wings are positioned over the ribs. Note the 
incomplete transection of the ribs to avoid any malposi- 
tion of the fragments. 
metal strut can remain in place for 1 year with no 
problems for the patient. 
3. An external strut, .like the bioabsorbable strut pro- 
posed by Matsui and associates, requires an extensive 
9 dissection of the anatomic planes to allow implantation. 
Internal fixation by the low-profile seagull wing prosthesis 
allows a minimal anatomic dissection. 
4. Cost and availability of the poly-L-lactide bioabsorb- 
able strut are unknown. The seagull wing prosthesis can 
be crafted in house and the cost is a few dollars for each 
prosthesis. 
We congratulate Matsui and colleagues for their 
innovative technique, but we will wait for long-term 
follow-up. Chest wall deformity can recur after several 
years. 
In our experience, the seagull wing prosthesis is 
safe, economical, easy to impIant and remove, and 
comfortable for the patient, and it does not traumatize 
the chest tissues. Moreover, it gives good results and 
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Fig. 2. Surgical removal of the prosthesis can be obtained by gentle traction, thanks to the particular 
composition of the strut (AISI 316 steel), with local anesthesia. 
Table I. Complications and esthetic results at 
follow-up in 315 patients with pectus excavatum in 
whom a self-retaining seagull wing prosthesis was 
used (1958 to 1991) 
No. of patients % 
Overall mortality 1 0.3 
Infections 4 1.3 
Re0peration 7 2.2 
Esthetic results 
Excellent 246 78 
Good 57 18 
Poor 12 4 
Mean hospital stay was 8.2 • 2.1 days. 
recurrence of chest wall deformity is virtually nonexist- 
ent. 
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Reply to the Editor: 
The letter in response to our article I states that (1) 
bioabsorbable material always induces undesirable reac- 
tions, unlike metal struts, which offer good biologic toler- 
ance; (2) the desirable stabilization period is often 6 to 8 
months; (3) external struts require more extensive dissec- 
tion; and (4) the cost and availability of poly-L-lactide 
struts are not clear. 
Our answers are as follows: 
1. Among a variety of bioabsorbable materials that have 
been investigated, polylactides are now applied clinically 
in the form of commercially available surgical suture 
materials uch as Vicryl polyglactin 910 (Ethicon, Inc., 
Somerville, N.J.) and Dexon polyglycolic acid (Davis & 
Geck, Danbury, Conn.). One of the peculiar characteris- 
tics of polylactides i that their decomposition products 
are glycolic and lactic acids, which are degraded via the 
normal metabolic pathway in tissues. In our previous 
study, we 2 clarified the details of polylactide degradation 
and found that they disappear in tissue without scar 
formation. Orthopedic devices such as screws and bone 
plates made from poly-L-lactide are also clinically avail- 
able. In our clinical study we had to remove broken struts 
from the surrounding granulation ssue in three patients. 
However, it is important o emphasize that excessive 
tissue reactions occurred only with poly-L-lactide plates 
that were not thick enough to support the underlying 
severe deformity, and the granulation tissue was thought 
